Semaglutide is a GLP-1 receptor agonist FDA-approved for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with a qualifying comorbidity. Residents of East Congress, Texas can access licensed Semaglutide prescriptions through telehealth — no in-person clinic visit required under Texas Occupations Code §111.001. Board-certified physicians review patient health assessments online and issue prescriptions within 24–48 hours. Compounded Semaglutide from an FDA-registered 503B outsourcing pharmacy ships overnight directly to your Austin address. Monthly cost: $199–$379 — vs. $1,247 for brand-name Ozempic or Wegovy. All prescribing physicians serving East Congress patients are licensed in Texas and regulated by the Texas Medical Board. Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Serving Austin ZIP codes: 78701, 78702, 78703, 78704, 78705.
Local clinics serving East Congress: Texas Weight Loss - South Austin, Bio-X Weight Loss Center (Austin) and Bluebonnet Weight Loss. Many patients compare these in-person options against licensed Semaglutide telehealth — prescribed online, shipped to the door.
Weight-Loss Injections seen from East Congress, without the jargon. This page is a starting point for comparing the injectable options available via telehealth before a medical evaluation.
A consultation, even online, exists precisely to check these criteria before any prescription. The goal of the evaluation is not to screen for the sake of screening, but to make sure the expected benefit outweighs the risks.
On the cost side, expect about $200-600/month depending on the molecule and format (compounded vs brand). depending on the format (brand vs compounded). Typical dosing: depends on the molecule chosen (semaglutide or tirzepatide) after evaluation. The area's median income (~$86,556) weighs on the brand-vs-compounded trade-off in East Congress. Around East Congress in Travis County, 3 weight-management practice(s) are listed locally.
Often a BMI of 30 or higher, or 27 or higher with a weight-related comorbidity, but only the medical evaluation decides.
The two main ones are semaglutide (GLP-1) and tirzepatide (dual GIP/GLP-1). Tirzepatide shows higher average loss in trials, but the choice depends on tolerance and cost.
The approved molecules (semaglutide, tirzepatide) have a documented safety profile under medical supervision; they require a prescription and monitoring.
Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Licensed in Texas. All prescriptions issued under Texas Occupations Code §111.001 and supervised by Texas Medical Board.